Janux Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.7M | 7.9M | 10.0M | 0 | 0 | 0 | 439K | 8.9M |
| Cost of Goods Sold | 469K | 8.9M | 501K | 29.2M | 25.1M | 20.8M | 2.4M | 506K |
| Gross Profit | 3.3M | -1.1M | 9.5M | -29.2M | -25.1M | -20.8M | -1.9M | 8.4M |
| R&D Expenses | 26.8M | 31.5M | 34.6M | 34.7M | 25.1M | 20.8M | 18.6M | 14.9M |
| Operating Expenses | 37.5M | 41.3M | 44.8M | 15.9M | 9.8M | 8.2M | 33.9M | 22.2M |
| Operating Income | -34.2M | -42.4M | -35.3M | -45.1M | -34.9M | -29.0M | -35.8M | -13.8M |
| Other Income / Gains | 9.9M | 10.5M | 10.9M | 11.3M | 11.4M | 8.8M | 7.8M | 7.9M |
| Net Income | -24.4M | -31.9M | -24.3M | -33.9M | -23.5M | -20.2M | -28.1M | -6.0M |
| EPS (Diluted) | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.874 | -0.135 | 0.95 | 0 | 0 | 0 | -4.408 | 0.943 |
| General And Administrative Expenses | 11.1M | 10.9M | 0 | 10.5M | 9.8M | 8.2M | 17.7M | 7.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -506K |
| Selling General And Administrative Expenses | 11.1M | 10.9M | 10.1M | 10.5M | 9.8M | 8.2M | 17.7M | 7.3M |
| Other Expenses | -469K | -1.1M | 0 | -29.2M | -25.1M | -20.8M | -2.4M | 0 |
| Cost And Expenses | 37.9M | 50.3M | 45.3M | 45.1M | 34.9M | 29.0M | 36.3M | 22.7M |
| Interest Income | 9.9M | 34.0M | 10.9M | 11.3M | 11.4M | 8.8M | 7.8M | 7.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 469K | 519K | 501K | 541K | 519K | 512K | 510K | 506K |
| Ebitda | -23.9M | -31.4M | -23.8M | -33.3M | -23.0M | -19.7M | -27.5M | -5.5M |
| Ebitdaratio | -6.40 | -3.988 | -2.381 | 0 | 0 | 0 | -62.754 | -0.613 |
| Operating Income Ratio | -9.165 | -5.381 | -3.525 | 0 | 0 | 0 | -81.645 | -1.554 |
| Income Before Tax | -24.4M | -31.9M | -24.3M | -33.9M | -23.5M | -20.2M | -28.1M | -6.0M |
| Income Before Tax Ratio | -6.526 | -4.054 | -2.431 | 0 | 0 | 0 | -63.916 | -0.67 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -6.526 | -4.054 | -2.431 | 0 | 0 | 0 | -63.916 | -0.67 |
| Epsdiluted | -0.39 | -0.51 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 |
| Weighted Average Shs Out | 62.7M | 62.0M | 62.0M | 61.9M | 61.8M | 56.8M | 54.6M | 54.5M |
| Weighted Average Shs Out Dil | 62.7M | 62.0M | 62.0M | 61.9M | 61.8M | 56.8M | 54.6M | 54.5M |